Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population

Vaccines (Basel). 2022 Nov 3;10(11):1859. doi: 10.3390/vaccines10111859.

Abstract

As an extremely contagious pathogen, a high rate of vaccine coverage and the durability of vaccine-induced immunity are key factors to control and eliminate measles. Herein, we assessed the seroprevalence of antibodies specific to measles in a cohort of 1393 adults (20-44 years old). ELISA results showed a nontrivial proportion of 37.6% study subjects being negative for measles immunoglobulin G (IgG). We also found significant influences of sex and age of the study cohort on the IgG level. Our findings suggest that even within a highly vaccinated population, a subset of individuals may still have sub-optimal immunity against measles and potentially be susceptible during any future measles outbreaks.

Keywords: MMR vaccine; measles virus; seroprevalence; serosurveillance; waning immunity.